Roots Analysis
AUGUST 15, 2023
We have put in our best effort to make it easily graspable what are the intracellular drug delivery technologies and how it can ensure effective treatment for fatal disease. Below are the highlights that we feel would be helpful to understand about the intracellular drug delivery / intracellular non-viral drug delivery approach.
Drug Discovery World
JULY 11, 2022
Klaus Cichutek, President of the Paul-Ehrlich-Institute who spoke about fighting the Covid-19 pandemic and Proessor Heinrich Haas, Vice President Formulation and Drug Delivery at BioNTech SE who spoke on the topic of nanotechnologies in the development of vaccines against cancer.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
JUNE 22, 2023
“This is part of our long-term business strategy of leveraging exosome-mediated delivery to create and enable genetic medicines such as gene therapy and genome editors”. The post Evox Therapeutics acquires exosome AAV technology from Codiak appeared first on Drug Discovery World (DDW).
Roots Analysis
SEPTEMBER 1, 2023
Blue Ocean Strategy Example: Foundation Medicine has developed a genomic profiling test that helps oncologists identify the best treatment options for their patients based on their genetic makeup. Furthermore, new drug delivery methods can also help reduce healthcare costs by reducing the need for frequent doctor visits and hospitalizations.
The Pharma Data
JUNE 7, 2023
LNPs are spheric drug delivery bodies which can be equipped with therapeutic payloads for intracellular delivery. “Adding Acuitas’ clinically-validated and scalable LNP technology to our genomic medicine toolbox is another important step to advance our leadership in the field of cell and gene therapies.”
The Pharma Data
SEPTEMBER 1, 2021
The approach allows those cells to remain in the body for a long time and secrete a drug whenever there is a flare of inflammation.” The researchers used CRISPR-Cas9 genome editing technology to make cells that secrete a biologic drug in response to inflammation. ” The new findings are published online Sept.
The Pharma Data
APRIL 8, 2021
Advances in Drug Delivery (Session #ADT08), with a discussion on the advances and innovations fueling the development of the next generation of antibody drug conjugates. A pooled analysis of interstitial lung disease data in patients treated with Enhertu across eight cancer trials.
Expert insights. Personalized for you.
52 
Let's personalize your content